Elizabeth S Mayne1, Jaya A George. 1. aDepartment of Molecular Medicine and Haematology bDepartment of Chemical Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Services, Johannesburg, South Africa.
Abstract
PURPOSE OF REVIEW: HIV-infected individuals have improved access to antiretroviral therapy. This has resulted in a shift in causes of mortality from infectious diseases to noncommunicable diseases including cardiovascular disease, chronic kidney disease (CKD) and malignancies. This review will look at the epidemiological shift, risk factors for the development of these diseases and examine some of the supporting laboratory diagnostic testing, which may be required. RECENT FINDINGS: Risk factors for the development of these diseases in HIV-infected patients include underlying genetic predisposition, lifestyle risk factors, chronic inflammation as a consequence of HIV infection, the presence and persistence of opportunistic infections and in some cases, highly active antiretroviral therapy, itself. Morbidity and mortality from HIV-associated conditions are increasing in low-income and middle-income countries (LMICs) with increased prevalence of HIV-associated cancers, cardiovascular disease and CKD. SUMMARY: Management of these conditions in LMICs requires an integrated pathology solution that will enable early screening, diagnosis and monitoring.
PURPOSE OF REVIEW: HIV-infected individuals have improved access to antiretroviral therapy. This has resulted in a shift in causes of mortality from infectious diseases to noncommunicable diseases including cardiovascular disease, chronic kidney disease (CKD) and malignancies. This review will look at the epidemiological shift, risk factors for the development of these diseases and examine some of the supporting laboratory diagnostic testing, which may be required. RECENT FINDINGS: Risk factors for the development of these diseases in HIV-infectedpatients include underlying genetic predisposition, lifestyle risk factors, chronic inflammation as a consequence of HIV infection, the presence and persistence of opportunistic infections and in some cases, highly active antiretroviral therapy, itself. Morbidity and mortality from HIV-associated conditions are increasing in low-income and middle-income countries (LMICs) with increased prevalence of HIV-associated cancers, cardiovascular disease and CKD. SUMMARY: Management of these conditions in LMICs requires an integrated pathology solution that will enable early screening, diagnosis and monitoring.
Authors: Nazik Elmalaika Husain; Mohamed H Ahmed; Ahmed O Almobarak; Sufian K Noor; Wadie M Elmadhoun; Heitham Awadalla; Clare L Woodward; Dushyant Mital Journal: J Clin Med Res Date: 2017-12-01
Authors: André P Dos Santos; Anderson M Navarro; Andiara Schwingel; Thiago C Alves; Pedro P Abdalla; Ana Claudia R Venturini; Rodrigo C de Santana; Dalmo R L Machado Journal: BMC Public Health Date: 2018-06-27 Impact factor: 3.295
Authors: Emily P Hyle; Bongani M Mayosi; Keren Middelkoop; Mosepele Mosepele; Emily B Martey; Rochelle P Walensky; Linda-Gail Bekker; Virginia A Triant Journal: BMC Public Health Date: 2017-12-15 Impact factor: 3.295
Authors: Udeme E Ekrikpo; Effiong E Akpan; John U Ekott; Aminu K Bello; Ikechi G Okpechi; Andre P Kengne Journal: BMJ Open Date: 2018-07-19 Impact factor: 2.692